No concerns from me, Investment Houses have many reasons to...

No concerns from me, Investment Houses have many reasons to sell, they also have just as many to Buy. I watched one NZ fund trade a Biotech over the period of two years, sometimes timing it right sometimes timing it wrong... Many funds don't like to carry over a Binary decision pending , with the increases so far in IMU some could easily sell half their holding and still have a free carry into the results period.
On the issue of comments made by management regarding data,,, The Data Analysis is carried out by independent third party providers, so although management might be privileged to raw data, the analysis is what forms the market announcement.
Normally I would have sold this company by now as I have exceeded all of my normal set margins, But with results not that far away and additionally the company is cashed up after the recent placement $8.7m, these place the company is an a very strong position,,,, but don't under estimate the Bio-Tech RISK,, it's simple with a Biotech,,if it does what it says on the Can ,,,you can name your price... if it doesn't,,it's mystery meat and you can't even give it away....